| 5760 |
Centers for Disease Control and Prevention |
Html |
en |
Phosdrin - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6543 |
Centers for Disease Control and Prevention |
Html |
en |
Developing a Vaccine - Dengue Fever |
CDC Works For You 24/7 Protecting People - Working to Protect Against the Dangers of Dengue - Dengue, a painful and sometimes deadly viral disease transmitted by mosquitoes, threatens more than 3.5 billion people worldwide. Dengue is endemic in at least 100 countries in Southeast Asia, the Pacific Islands, the Caribbean, Central America, South America, and parts of Africa. As many as 100 million people become infected yearly, and nearly 500,000, mostly children, develop the potentially deadly dengue hemorrhagic fever. |
| dengue-endemic countries | 0.214985 |
| Dr. Claire Huang | 0.215187 |
| adequate immune response | 0.207263 |
| dengue virus | 0.589495 |
| dengue vaccine team | 0.643072 |
| licensed vaccine | 0.322353 |
| potentially deadly diseases | 0.219707 |
| dengue type | 0.450026 |
| dengue | 0.910174 |
| successful dengue vaccine | 0.74986 |
|
| affordable dengue vaccine | 0.656891 |
| human vaccine | 0.26153 |
| dengue hemorrhagic fever | 0.565163 |
| dengue shock syndrome | 0.557272 |
| human Phase-I trial | 0.202151 |
| dengue vaccine | 0.864035 |
| dengue vaccine candidate | 0.6995 |
| Colorado-based vaccine manufacturer | 0.3487 |
| dengue viruses | 0.713186 |
| multiple dengue viruses | 0.569569 |
|
CLICK HERE |
| 7397 |
Centers for Disease Control and Prevention |
Html |
en |
Incinerator Air Emissions - Inhalation Exposure Perspectives |
The Centers for Disease Control and Prevention provides independent oversight to the U.S. chemical weapons elimination program and serves as an important element in ensuring the safe destruction of chemical warfare material for protection of public health. |
| Ambient Air Level | 0.655409 |
| average exposure concentrations | 0.654909 |
| public health policy | 0.633319 |
| emission levels | 0.637775 |
| health screening values | 0.680681 |
| Nordic TEQ model | 0.657539 |
| J.I. DFS incinerator | 0.696034 |
| ambient air concentration | 0.688289 |
| ambient air data | 0.662782 |
| human exposure levels | 0.639566 |
| urban air concentrations | 0.683519 |
| dioxin TEQ mass | 0.667052 |
| stack emissions | 0.647359 |
| human exposure | 0.68634 |
| DFS TEQ | 0.635243 |
| Incinerator air emissions | 0.810592 |
| human health | 0.681677 |
| ambient air quality | 0.644974 |
| International TEQ model | 0.659935 |
| typical ambient air | 0.641983 |
| large prototype incinerator | 0.701814 |
| ambient air levels | 0.747841 |
| annual average exposure | 0.642675 |
| public health | 0.759089 |
|
| air emission data | 0.679336 |
| U.S. Public Health | 0.634335 |
| ambient air averages | 0.637428 |
| air exposure\inhalation pathway | 0.635725 |
| temporary incinerator | 0.647837 |
| dioxin TEQ | 0.673233 |
| trial burns | 0.671101 |
| ambient air values | 0.647363 |
| incinerators | 0.648341 |
| TEQ levels | 0.678985 |
| major new facility | 0.663039 |
| pollutants | 0.654372 |
| incinerator | 0.84039 |
| urban air | 0.711058 |
| stack emission pollutants | 0.636293 |
| screening values | 0.749282 |
| ambient air | 0.908931 |
| likely air concentrations | 0.647179 |
| Incinerator air emission | 0.770915 |
| incinerator emissions | 0.667825 |
| urban air data | 0.643233 |
| pg mass TEQ | 0.654567 |
| potential human exposure | 0.685304 |
|
CLICK HERE |
| 7574 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Tuberculosis Outbreak in a Long-Term-Care Facility for Mentally Ill Persons - Puerto Rico, 2010-2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| latent TB infection | 0.990411 |
| chest radiography | 0.879005 |
| Puerto Rico | 0.765375 |
| radiography equipment | 0.711307 |
| severe mental illness | 0.984963 |
| TB clinic | 0.836228 |
| original MMWR paper | 0.661067 |
| U.S. Government Printing | 0.654831 |
| Human Services | 0.641949 |
| TB disease | 0.818603 |
| Puerto Rico Department | 0.69315 |
| MMWR HTML versions | 0.654801 |
| U.S. Department | 0.642042 |
| on-site radiography equipment | 0.703519 |
| TB transmission | 0.771754 |
| median estimated length | 0.681513 |
| long-term–care facility | 0.640859 |
| tuberculin skin testing | 0.66549 |
| electronic PDF version | 0.654279 |
| Median age | 0.614269 |
| TB infection treatment | 0.840468 |
| local TB clinic | 0.830674 |
| outbreak genotype | 0.620703 |
|
| Kanako Ishida | 0.655543 |
| medical facility | 0.621266 |
| extended infectious periods | 0.776337 |
| symptom screening | 0.647505 |
| TB Prevention | 0.747433 |
| tuberculin skin | 0.76171 |
| W. Randolph Daley | 0.650503 |
| Puerto Rico Dept | 0.654449 |
| tuberculin skin tests | 0.669876 |
| long-term–care facilities | 0.648587 |
| Medicaid beneficiary residents | 0.686675 |
| TB education | 0.754413 |
| Development Program Office | 0.653512 |
| facility resident | 0.746127 |
| facility residents | 0.698336 |
| original paper copy | 0.648028 |
| TB Elimination | 0.745834 |
| Juan metropolitan area | 0.677816 |
| Mycobacterium tuberculosis genotype | 0.701808 |
| respiratory failure | 0.670494 |
| positive tuberculin skin | 0.668253 |
| human immunodeficiency virus | 0.667365 |
| facility employees | 0.685225 |
|
CLICK HERE |
| 9031 |
Centers for Disease Control and Prevention |
Html |
en |
Division of Laboratory Sciences - Training Opportunities |
null |
| Ridge Associated Universities | 0.959269 |
| CDC | 0.219065 |
| environmental health initiatives | 0.825511 |
| diverse array | 0.5717 |
| public health infrastructures | 0.880086 |
|
| ORISE | 0.34542 |
| control programs | 0.46786 |
| prevention strategy goal | 0.816144 |
| implement prevention | 0.51091 |
| Energy facility | 0.548595 |
|
CLICK HERE |
| 10369 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Evaluation of the Effectiveness of a Problem-Solving Intervention Addressing Barriers to Cardiovascular Disease Prevention Behaviors in 3 Underserved Populations: Colorado, North Carolina, West Virginia, 2009 - CDC |
In low-income and underserved populations, financial hardship and multiple competing roles and responsibilities lead to difficulties in lifestyle change for cardiovascular disease (CVD) prevention. To improve CVD prevention behaviors, we adapted, pilot-tested, and evaluated a problem-solving intervention designed to address barriers to lifestyle change. |
| North Carolina | 0.561355 |
| study participants | 0.515514 |
| group leader | 0.509834 |
| program | 0.544592 |
| research centers program | 0.5188 |
| CVD prevention behaviors | 0.524163 |
| health intervention research | 0.637595 |
| CVD risk | 0.541968 |
| cardiovascular health intervention | 0.634973 |
| problem-solving program | 0.529321 |
| sessions | 0.581997 |
| group format | 0.531521 |
| stressful life circumstances | 0.768566 |
| American Heart Association | 0.511104 |
| social problem-solving theory | 0.529922 |
| daily fruit | 0.526532 |
| total study group | 0.548428 |
| intervention | 0.671462 |
| problem-solving therapy | 0.573532 |
| prevention research | 0.549259 |
| problem-solving approach | 0.521601 |
| West Virginia University | 0.524424 |
| Diabetes problem-solving scale | 0.519741 |
| New Leaf program | 0.532851 |
| Likert-type response scale | 0.508564 |
|
| PRC CHIRTN | 0.531378 |
| behavioral self-management intervention | 0.528827 |
| Anschutz Medical Campus | 0.520974 |
| problem-solving intervention | 0.599678 |
| intervention study | 0.513257 |
| heart disease | 0.551488 |
| change intervention approach | 0.539444 |
| pair-wise comparisons | 0.516654 |
| New Leaf materials | 0.513435 |
| 5-point Likert-type response | 0.509774 |
| Health Problem-Solving Scale | 0.541788 |
| daily physical activity | 0.5209 |
| problem-solving skills | 0.695544 |
| participants | 0.706344 |
| intervention program | 0.512096 |
| cardiovascular disease | 0.525546 |
| vegetable intake | 0.604 |
| focus group participants | 0.550911 |
| physical activity | 0.961611 |
| problem-solving workbook | 0.520246 |
| site | 0.657532 |
| New Leaf | 0.557234 |
| et al | 0.60028 |
| intervention implementation | 0.518105 |
|
CLICK HERE |
| 11419 |
Centers for Disease Control and Prevention |
Html |
null |
Campaign Partners | We Can Stop HIV One Conversation | Campaigns | Act Against AIDS |
List of partner organizations of One Conversation at a Time, CDC’s first national effort to encourage Hispanic/Latino families, friends, and communities to talk openly about HIV |
|
|
CLICK HERE |
| 11442 |
Centers for Disease Control and Prevention |
Html |
en |
Strengthening Public Health Leadership in Central America and the Dominican Republic | CDC Global Health |
null |
| Central American Professionals | 0.450003 |
| Central America | 0.780417 |
| regional health activities | 0.495749 |
| regional coordinating body | 0.448972 |
| Health Plan | 0.369443 |
| CDC Director | 0.420247 |
| Health Surveillance | 0.376407 |
| Sentinel Surveillance services | 0.397863 |
| Central American | 0.665386 |
| central american region | 0.594588 |
| President Pro Tempore | 0.382137 |
| regional health | 0.544119 |
| valuable collaborative work | 0.371036 |
| WHO/PAHO International Health | 0.448332 |
| Dr. Nelson Arboleda | 0.393793 |
| regional health issues | 0.497706 |
| brilliant ice breaker | 0.378642 |
| health emergencies | 0.363185 |
| CDC’s role | 0.421002 |
| Dr. Oliver Morgan | 0.384032 |
| Government Global Health | 0.430511 |
| National Strategic Plans | 0.397301 |
| relevant diagnostic tools | 0.389146 |
| threat Central America | 0.420888 |
|
| Dominican Republic Office | 0.433335 |
| International Health Regulations | 0.614654 |
| bi-annual governance meeting | 0.387842 |
| Health Security Agenda | 0.575118 |
| public health information | 0.451561 |
| Dr. Cristina Rabadán-Diehl | 0.39859 |
| important public health | 0.442193 |
| Global Health Security | 0.574451 |
| CDC Central American | 0.586348 |
| central american integration | 0.600263 |
| regional health officials | 0.489591 |
| Dr. Valdés | 0.423898 |
| epidemiological surveillance systems | 0.39776 |
| health services | 0.362876 |
| CDC’s Central | 0.446025 |
| Dr. Tom Frieden | 0.405849 |
| collaborative work | 0.380408 |
| public health | 0.521032 |
| laboratory quality assurance | 0.384429 |
| HIV/AIDS health indicators | 0.445524 |
| COMISCA member countries | 0.41825 |
| Dr. Lorenzo Hidalgo | 0.400374 |
| Regional Health Policy | 0.473637 |
| Dominican Republic | 0.970683 |
|
CLICK HERE |
| 11779 |
Centers for Disease Control and Prevention |
Html |
es |
Lo que los padres deben saber sobre el enterovirus D68 |
Cada año, millones de niños en los Estados Unidos contraen enterovirus que pueden causar tos, estornudos y fiebre. Este año, el enterovirus que más frecuentemente está causando enfermedad respiratoria en los niños en todo el país es el enterovirus D68 (EV-D68). Tome medidas básicas para que su hijo no contraiga y propague el EV-D68. |
| Archivo Apple Quicktime | 0.389379 |
| largo plazo | 0.357444 |
| Archivo Zip Comprimido | 0.388246 |
| enterovirus d68 | 0.931271 |
| infecciones respiratorias | 0.361937 |
| Archivo Microsoft PowerPoint | 0.395675 |
|
| Archivo Adobe PDF | 0.388428 |
| Archivo Microsoft Excel | 0.387648 |
| enfermedad respiratoria | 0.895414 |
| Estados Unidos | 0.717643 |
| Archivo Microsoft | 0.55385 |
|
CLICK HERE |
| 14118 |
Centers for Disease Control and Prevention |
Html |
en |
Advisory Committee on Immunization Practices RecommendedImmunization Schedules for Persons Aged 0 Through 18 Years - UnitedStates, 2016 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| clinical decision making | 0.641097 |
| post-vaccination serologic testing | 0.618909 |
| Haemophilus influenzae type | 0.534185 |
| American Academy | 0.632097 |
| inactivated polio vaccine | 0.583431 |
| immunization schedule website | 0.691581 |
| advisory committee | 0.593339 |
| CDC website | 0.554861 |
| Drug Administration-licensed vaccines | 0.614372 |
| Family Physicians | 0.535596 |
| health care providers | 0.674515 |
| childhood/adolescent immunization schedules | 0.696911 |
| meningococcal vaccines footnote | 0.628072 |
| preferred age range | 0.533289 |
| CDC immunization schedule | 0.745004 |
| meningococcal b vaccine | 0.603782 |
| sexual abuse | 0.535558 |
| persons | 0.535315 |
| displays current schedules | 0.576952 |
| Work Group Contributors | 0.526277 |
| high risk | 0.720961 |
| human papillomavirus | 0.539991 |
| ACIP Child/Adolescent Immunization | 0.726167 |
| accurate immunization schedules | 0.684934 |
| Catch-up immunization schedule | 0.646998 |
|
| content syndication | 0.528764 |
| immunization schedule | 0.828821 |
| oral poliovirus vaccine | 0.580845 |
| age group | 0.529172 |
| clearly present recommendations | 0.553152 |
| individual clinical decision | 0.641116 |
| Meningococcal B vaccines | 0.542403 |
| Immunization Practices | 0.725024 |
| specific vaccines | 0.536908 |
| American College | 0.627209 |
| Work Group members | 0.530984 |
| possible previous vaccines | 0.588382 |
| current immunization schedules | 0.701733 |
| ACIP vaccine recommendations | 0.737373 |
| website (http://www.cdc.gov/vaccines/schedules/index.html). | 0.562575 |
| DTaP vaccine | 0.529078 |
| Work Group | 0.621063 |
| vaccine footnote | 0.676563 |
| ACIP recommendations | 0.582281 |
| new HPV vaccine | 0.58826 |
| Work Group chair | 0.528218 |
| immunization schedules | 0.974812 |
| readers electronic access | 0.544145 |
| purple bar | 0.589637 |
|
CLICK HERE |